Glucocorticoids Toxicity: Clinical Trials

2 trials for Glucocorticoids Toxicity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow Glucocorticoids Toxicity: new trials by email Literature Review of Glucocorticoids Toxicity trials Research Report on Glucocorticoids Toxicity

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Romosozumab Versus Denosumab in Glucocorticoid-induced Osteoporosis: an Extended Observation of a Randomized Controlled Trial at 48 Months
Romosozumab, Denosumab - Osteoporosis, Glucocorticoids Toxicity
Phase 4CompletedTuen Mun Hospital542024-08-202026-05-05
Liver Function After Intravenous Methylprednisolone Administration
every week IVMP therapy, very high doses IVMP therapy - Graves Disease, Graves Ophthalmopathy
Phase 4CompletedMedical University of Warsaw682012-01-012018-09-13

Narrower conditions

Chemical and Drug Induced Liver Injury (1)  ·  Fractures, Bone (1)  ·  Graves Disease (1)  ·  Graves Ophthalmopathy (1)  ·  Hepatic Insufficiency (1)  ·  Liver Diseases (1)  ·  Liver Failure (1)  ·  Liver Failure, Acute (1)  ·  Osteoporosis (1)

Broader conditions

Autoimmune Diseases (1)  ·  Bone Diseases (1)  ·  Bone Diseases, Metabolic (1)  ·  Chemically-Induced Disorders (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Diseases (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Endocrine System Diseases (1)  ·  Exophthalmos (1)  ·  Eye Diseases (1)  ·  Eye Diseases, Hereditary (1)  ·  Genetic Diseases, Inborn (1)  ·  Goiter (1)  ·  Hyperthyroidism (1)  ·  Immune System Diseases (1)

Interventions

Denosumab (1)  ·  romosozumab (1)

Sponsors

Medical University of Warsaw (1)  ·  Tuen Mun Hospital (1)

Countries

China (1)

Top investigators

Chi Chiu Mok, MD, FRCP (1)

Results publications

PMID 30420883